Correlation Between Genomma Lab and Sumitomo Dainippon
Can any of the company-specific risk be diversified away by investing in both Genomma Lab and Sumitomo Dainippon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genomma Lab and Sumitomo Dainippon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genomma Lab Internacional and Sumitomo Dainippon Pharma, you can compare the effects of market volatilities on Genomma Lab and Sumitomo Dainippon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genomma Lab with a short position of Sumitomo Dainippon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genomma Lab and Sumitomo Dainippon.
Diversification Opportunities for Genomma Lab and Sumitomo Dainippon
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Genomma and Sumitomo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Genomma Lab Internacional and Sumitomo Dainippon Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sumitomo Dainippon Pharma and Genomma Lab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genomma Lab Internacional are associated (or correlated) with Sumitomo Dainippon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sumitomo Dainippon Pharma has no effect on the direction of Genomma Lab i.e., Genomma Lab and Sumitomo Dainippon go up and down completely randomly.
Pair Corralation between Genomma Lab and Sumitomo Dainippon
If you would invest (100.00) in Sumitomo Dainippon Pharma on December 30, 2024 and sell it today you would earn a total of 100.00 from holding Sumitomo Dainippon Pharma or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Genomma Lab Internacional vs. Sumitomo Dainippon Pharma
Performance |
Timeline |
Genomma Lab Internacional |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Sumitomo Dainippon Pharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Genomma Lab and Sumitomo Dainippon Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Genomma Lab and Sumitomo Dainippon
The main advantage of trading using opposite Genomma Lab and Sumitomo Dainippon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genomma Lab position performs unexpectedly, Sumitomo Dainippon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sumitomo Dainippon will offset losses from the drop in Sumitomo Dainippon's long position.Genomma Lab vs. Speakeasy Cannabis Club | Genomma Lab vs. City View Green | Genomma Lab vs. Benchmark Botanics | Genomma Lab vs. Hypera SA |
Sumitomo Dainippon vs. Hypera SA | Sumitomo Dainippon vs. YourWay Cannabis Brands | Sumitomo Dainippon vs. Cumberland Pharmaceuticals | Sumitomo Dainippon vs. Speakeasy Cannabis Club |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |